Drug Shortage Report for ACT OLANZAPINE ODT

Last updated on 2019-10-26 History
Report ID 93156
Drug Identification Number 02327562
Brand name ACT OLANZAPINE ODT
Common or Proper name OLANZAPINE ODT
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) OLANZAPINE
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 30
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-09-05
Estimated end date Unknown
Actual end date 2019-10-25
Shortage status Resolved
Updated date 2019-10-26
Company comments Item is discontinued
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-09-05 English Compare
v2 2019-09-05 French Compare
v3 2019-09-06 English Compare
v4 2019-10-25 English Compare
v5 2019-10-25 French Compare
v6 2019-10-26 English Compare